Open main menu

HemOnc.org - A Hematology Oncology Wiki β

Related changes

Tisagenlecleucel (Kymriah)

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 16:16, 22 September 2019
 
 
Page name:

15 September 2019

 m   17:12  Diffuse large B-cell lymphoma‎‎ (5 changes | history) . . (+1,008). . [Jwarner‎ (5×)]
 m    17:12 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:60fc19|Variant=1}})
 m    16:58 (cur | prev) . . (+13). . Jwarner (talk | contribs) (Chemotherapy)
 m    16:57 (cur | prev) . . (+977). . Jwarner (talk | contribs)
 m    16:47 (cur | prev) . . (+10). . Jwarner (talk | contribs) (BR & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m    16:47 (cur | prev) . . (+3). . Jwarner (talk | contribs) (BR & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m   17:11  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)